{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-193510","form_type":"8-K","ticker":"IQV","cik":"0001478242","company_name":"IQVIA HOLDINGS INC.","filed_at":"2025-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.075663+00:00","generated_at":"2026-05-17T08:50:06.368085+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"IQVIA appoints Michael Fedock as CFO; Ron Bruehlman to retire Feb 28, 2026","bullets":["Michael Fedock, currently SVP of FP&A, becomes EVP and CFO effective February 28, 2026.","Ron Bruehlman retires as CFO and transitions to Senior Advisor to the CEO.","Fedock's base salary rises to $750,000 with annual cash incentive target of 100% of base salary; eligible for LTI grants.","Fedock has over 25 years in healthcare, including CFO roles at IQVIA Laboratories and R&D Solutions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-193510","json":"https://secwatch.observer/filing/0001193125-25-193510.json","markdown":"https://secwatch.observer/filing/0001193125-25-193510.md","text":"https://secwatch.observer/filing/0001193125-25-193510.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478242/000119312525193510/0001193125-25-193510-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478242/000119312525193510/d37930d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:50:06.368085+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}